The Benefits of Nostalgia-Based Virtual Reality Brain Health Interventions on Nostalgia Tendencies, Life Satisfaction, Psychological Well-Being, Depression Levels, and Cognitive Function in Older Adults
Launched by NATIONAL TAIWAN NORMAL UNIVERSITY · May 14, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This randomized controlled trial (RCT) aims to examine the effectiveness of a nostalgia-based virtual reality (VR) intervention on improving cognitive function, emotional well-being, nostalgia proneness, and mental health among older adults in northern Taiwan. The study specifically targets community-dwelling older adults aged 65 years and above, including individuals diagnosed with mild cognitive impairment (MCI) or mild dementia.
Participants are recruited from government-registered long-term care facilities in northern Taiwan. Inclusion criteria include being 65 years or older, capable ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 65 years or older, Able to communicate in Mandarin or Taiwanese, Capable of wearing and operating a VR headset and handheld controllers, Sufficient vision and hearing to interact with VR content (assistive devices allowed), Able to provide informed consent or have a legal guardian provide consent
- Exclusion Criteria:
- • Diagnosis of severe dementia or advanced neurodegenerative disease, Severe psychiatric disorders (e.g., schizophrenia, bipolar disorder), Major visual or auditory impairments that would interfere with VR use, even with assistive devices, Unconsciousness or inability to stay awake or focused for the session duration, Inability to comply with study protocol or scheduled sessions
About National Taiwan Normal University
National Taiwan Normal University (NTNU) is a prestigious institution dedicated to advancing education and research across various disciplines, including health sciences. As a clinical trial sponsor, NTNU leverages its academic expertise and innovative methodologies to investigate and develop novel therapeutic interventions. The university fosters collaboration between researchers, healthcare professionals, and industry partners to ensure rigorous study design, ethical standards, and comprehensive data analysis. By prioritizing scientific excellence and community health, NTNU aims to contribute significantly to the advancement of medical knowledge and the improvement of patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, Taipei City, Taiwan
Patients applied
Trial Officials
Jong-Long Guo, PhD
Study Chair
National Taiwan Normal University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported